Crossject expands executive board to five with Lacombe, Morin, Seltz appointments
Bitget2026/09/25 05:30- Crossject expanded its Executive Board to five members, appointing Olivier Lacombe, Didier Morin, Lionel Seltz with immediate effect.
- Lacombe joined in 2021, bringing 21 years in pharmaceutical development from Fournier, Abbott, Solvay, Inventiva.
- Morin joined in 2023, bringing 30 years in industrial operations from IDS, Axess Vision.
- Seltz joined in January 2026, bringing 25 years in life sciences finance from Cegedim, IQVIA/IMS Health, Mars Group.
- Crossject US appointed David Pudwill as VP, Regulatory & Scientific Affairs; he brings about 20 years’ experience, including nine at the FDA.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The Bank of Japan's interest rate hike still fails to impress the market! Hedge funds slash yen long positions by nearly 80%, while dollar long positions increase significantly
After the Bank of Japan failed to deliver a clear enough signal of further interest rate hikes to the market, hedge funds have significantly reduced their bullish bets on the yen.
US Treasury yields continue to rise! Cleveland Federal Reserve President: Government and AI compete for funds, fueling rate hike expectations
Cleveland Federal Reserve President Loretta Mester stated on Friday that the recent sustained rise in long-term U.S. Treasury yields is the result of multiple factors working together.
Crypto prices
More
